Biotechnology - Genomic and Proteomics/Overview of Economics of Intellectual Property in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
===Where does the literature says IP works and does not work?=== | ===Where does the literature says IP works and does not work?=== | ||
'''Where IP does work''' | |||
* More effective in industries with high R&D costs | |||
**“On average, a lack of patent protection would have prevented the development of 60% of pharmaceutical and 38% of chemical inventions. In most sectors, a lack of patent protection would have had little impact, resulting in 17% fewer inventions in machinery, 12% less in fabricated metals, 11% less in electrical equipment, and no effect at all in office equipment, motor vehicles, rubber, and textiles.” (Arundel pp. 11) | |||
* More effective in industries like Biotech, where (in the US) research methods can be patented | |||
**research tools develop faster in biotech than in other industries - so there's a profit to be had just coming up with new research processes (Harison pp. 26) | |||
**Current US IP law does not make a distinction between discovery and invention, could have possible impact on innovation (pp. 28) | |||
*Patents do work for strategic purposes - in fact, strategic use of patents seems to be becoming more commons | |||
**“The patenting strategies of American firms appear to be strongly driven by the wish to block competitors and to prevent copying. The use of patents as a means of sharing information, for example through licensing or in negotiations, is less important for American firms than for European and Japanese firms.” (Arundel pp. 13) | |||
'''Where IP doesn't work''' | |||
*Less effective in industries where lead time provides big advantages | |||
**von Hippel and Levin both found that companies preferred to protect innovations through secrecy and lead times (pp. 3) | |||
*In general patents less important than other methods of capitalizing on innovation (Arundel pp. 7-8. Graph on 8) | |||
*Patents do not work well for spreading information | |||
**only a small number (3%) of high technology firms use patent and copyright publications sources of new information. Compare to trade conferences: 70% (pp. 3,5) | |||
===What are the other incentives mentioned by the literature?=== | ===What are the other incentives mentioned by the literature?=== | ||
===is there data on "how much of an increase of the tendency towards enclosure".=== | ===is there data on "how much of an increase of the tendency towards enclosure".=== | ||
sub-question: e.g. how much does the biotechnology field have patented? Has this movement increased over time? | sub-question: e.g. how much does the biotechnology field have patented? Has this movement increased over time? |
Revision as of 21:43, 10 March 2009
Where does the literature says IP works and does not work?
Where IP does work
- More effective in industries with high R&D costs
- “On average, a lack of patent protection would have prevented the development of 60% of pharmaceutical and 38% of chemical inventions. In most sectors, a lack of patent protection would have had little impact, resulting in 17% fewer inventions in machinery, 12% less in fabricated metals, 11% less in electrical equipment, and no effect at all in office equipment, motor vehicles, rubber, and textiles.” (Arundel pp. 11)
- More effective in industries like Biotech, where (in the US) research methods can be patented
- research tools develop faster in biotech than in other industries - so there's a profit to be had just coming up with new research processes (Harison pp. 26)
- Current US IP law does not make a distinction between discovery and invention, could have possible impact on innovation (pp. 28)
- Patents do work for strategic purposes - in fact, strategic use of patents seems to be becoming more commons
- “The patenting strategies of American firms appear to be strongly driven by the wish to block competitors and to prevent copying. The use of patents as a means of sharing information, for example through licensing or in negotiations, is less important for American firms than for European and Japanese firms.” (Arundel pp. 13)
Where IP doesn't work
- Less effective in industries where lead time provides big advantages
- von Hippel and Levin both found that companies preferred to protect innovations through secrecy and lead times (pp. 3)
- In general patents less important than other methods of capitalizing on innovation (Arundel pp. 7-8. Graph on 8)
- Patents do not work well for spreading information
- only a small number (3%) of high technology firms use patent and copyright publications sources of new information. Compare to trade conferences: 70% (pp. 3,5)
What are the other incentives mentioned by the literature?
is there data on "how much of an increase of the tendency towards enclosure".
sub-question: e.g. how much does the biotechnology field have patented? Has this movement increased over time?